Jason Wittes
Stock Analyst at Roth Capital
(2.56)
# 2,356
Out of 5,056 analysts
61
Total ratings
47.17%
Success rate
3.09%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $7.08 | +464.97% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $359.39 | +26.88% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $1.39 | +1,051.08% | 2 | Mar 21, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $2.72 | +488.21% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $14.48 | +51.93% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $85.68 | -15.97% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $4.52 | +143.36% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $83.54 | +37.66% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $11.35 | +217.18% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $8.13 | +35.30% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.02 | +880.39% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $87.02 | +14.92% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.21 | +126.24% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.99 | +813.24% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $28.57 | +162.51% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $20.14 | +9.24% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $89.48 | +34.11% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $146.69 | +40.43% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $170.03 | -14.72% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $14.88 | +0.84% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $11.49 | +1,640.64% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $31.14 | -16.51% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $7.08
Upside: +464.97%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $359.39
Upside: +26.88%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $1.39
Upside: +1,051.08%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $2.72
Upside: +488.21%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $14.48
Upside: +51.93%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $85.68
Upside: -15.97%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.52
Upside: +143.36%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $83.54
Upside: +37.66%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $11.35
Upside: +217.18%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $8.13
Upside: +35.30%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.02
Upside: +880.39%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $87.02
Upside: +14.92%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.21
Upside: +126.24%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $0.99
Upside: +813.24%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $28.57
Upside: +162.51%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $20.14
Upside: +9.24%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $89.48
Upside: +34.11%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $146.69
Upside: +40.43%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $170.03
Upside: -14.72%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $14.88
Upside: +0.84%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $11.49
Upside: +1,640.64%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $31.14
Upside: -16.51%